Latest Reports

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2019-2028

The global kidney cancer therapeutics and diagnostics market is projected to register a CAGR of 5.52% between 2019 and 2028, and is anticipated to generate revenue of $ 7966.9 million by 2028. Kidney cancer is often associated with various comorbidities. Therefore, its timely diagnosis and therapy are of utmost importance for a better quality of life. Due to the rising prevalence of kidney cancer in every part of the world, various governments and research organizations... Read more

ASIA PACIFIC KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2019-2028

The Asia Pacific kidney cancer therapeutics and diagnostics market is projected to record a CAGR of 5.92% during the forecast period, 2019-2028. The surging number of kidney cancer cases in the region is primarily driving the growth of the market. South Korea, Japan, India, Vietnam, Thailand, Australia & New Zealand, Indonesia, Vietnam, and the rest of Asia Pacific, are analyzed for evaluating the Asia Pacific kidney cancer therapeutics and diagnostics market growth. In China, the... Read more

EUROPE KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2019-2028

The Europe kidney cancer therapeutics and diagnostics market is projected to register a CAGR of 5.36% during the forecast period, 2019-2028. The rising incidence of kidney cancer cases and the increasing prevalence of transplants are among the primary drivers of market growth in the region. The United Kingdom, Germany, France, Russia, Italy, Poland, Belgium, and the rest of Europe, are assessed for the Europe kidney cancer therapeutics and diagnostics market growth analysis. Germany has the... Read more

NORTH AMERICA KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2019-2028

The North America kidney cancer therapeutics and diagnostics market is estimated to register a CAGR of 5.59% during the forecast period, 2019-2028. The increasing government initiatives and the presence of established players are the major factors propelling the market growth of the region. The United States and Canada are evaluated in the North America kidney cancer therapeutics and diagnostics market growth analysis. NORTH AMERICA KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST 2019-2028 North America Kidney... Read more

GLOBAL MOLECULAR POINT OF CARE DIAGNOSTICS MARKET FORECAST 2019-2028

The global molecular point of care diagnostics market is estimated to grow with a CAGR of 14.90% by revenue, during the year 2019-2028.  The market is anticipated to acquire a revenue of about $8382.15 Million by 2028.  The base year considered for the study is 2018. The projected period is between 2019 and 2028. Currently, the market is majorly driven by the need for diagnosing SARS-CoV-2 patients. As of now, there are no treatments available, and... Read more